Shandong Weigao Medical Polymer Co. (OTCMKTS:SHWGF) Short Interest Up 105.6% in August

Key Points

• Shandong Weigao Medical Polymer Co. experienced a significant increase in short interest of 105.6% in August, rising from 10,392,000 shares to 21,362,600 shares.
• The company's stock price remained flat at $0.76 during midday trading, with a 12-month high also recorded at this price.
• Shandong Weigao operates in the medical device sector, focusing on research, development, and the sale of various medical products in China.

Shandong Weigao Medical Polymer Co. (OTCMKTS:SHWGF - ) was the target of a large growth in short interest during the month of August. As of August 31st, there was short interest totaling 21,362,600 shares, a growth of 105.6% from the August 15th total of 10,392,000 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days. Currently, 0.5% of the shares of the stock are short sold. Currently, 0.5% of the shares of the stock are short sold. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

Shandong Weigao Medical Polymer Stock Performance

Shares of SHWGF remained flat at $0.76 during midday trading on Friday. The company has a fifty day moving average of $0.76 and a 200 day moving average of $0.75. Shandong Weigao Medical Polymer has a 12-month low of $0.65 and a 12-month high of $0.76. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.78 and a current ratio of 3.20.

About Shandong Weigao Medical Polymer

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.